OptiNose, Inc. (NASDAQ:OPTN) Q3 2024 Earnings Call Transcript
Operator: Good day, and welcome to the OptiNose Third Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Optinose Inc. (OPTN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 986,031 | $6,586,687 | 0.28% | |
| 2. | Stonepine Capital Timothy P. Lynch | 588,657 | $3,932,229 | 3.17% | |
| 3. | Kingdon Capital Mark Kingdon | 373,281 | $2,493,517 | 0.35% | |
| 4. | Great Point Partners Jeffrey Jay And David Kroin | 370,269 | $2,473,397 | 1.16% | |
| 5. | D E Shaw D. E. Shaw | 333,333 | $2,226,664 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.06 | 34,000 | Officer | 142,278 | 2021-05-20 | Filing | |
| $2.99 | 10,000 | Director | 31,230 | 2021-05-10 | Filing | |
| $3.91 | 11,742 | Officer, Director | 636,955 | 2021-03-18 | Filing | |
| $3.85 | 787 | Officer, Director | 625,213 | 2021-03-17 | Filing | |
| $3.90 | 2,500 | Officer | 9,751 | 2020-09-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.61 | 246 | Officer | 55,038 | 2025-03-18 | Filing | |
| $5.61 | 368 | Officer, Director | 126,563 | 2025-03-18 | Filing | |
| $5.29 | 1,223 | Officer | 32,647 | 2025-03-04 | Filing | |
| $5.29 | 2,145 | Officer | 55,284 | 2025-03-04 | Filing | |
| $5.29 | 6,376 | Officer, Director | 126,931 | 2025-03-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,072,199 | $7,162,290 | 0% | |
| 2. | 973,684 | $6,363,025 | 5.11% | |
| 3. | 876,996 | $5,858,333 | 2.99% | |
| 4. | 422,813 | $2,824,391 | 1.52% | |
| 5. | 269,675 | $1,801,429 | 0.45% |
News See All
OptiNose, Inc. (NASDAQ:OPTN) Q2 2024 Earnings Call Transcript
Operator: Hello, and welcome to the OptiNose Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
OptiNose, Inc. (NASDAQ:OPTN) Q1 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the OptiNose's Q1 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
OptiNose, Inc. (NASDAQ:OPTN) Q4 2023 Earnings Call Transcript
OptiNose, Inc. beats earnings expectations. Reported EPS is $-9.0E-5, expectations were $-0.1.
OptiNose, Inc. (NASDAQ:OPTN) Q3 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to OptiNose Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
OptiNose, Inc. (NASDAQ:OPTN) Q2 2023 Earnings Call Transcript
Operator: Hello. Good day everyone and thank you for standing by. Welcome to the OptiNose Second Quarter 2023 Earnings Call. At this time, all participants are in a listen only mode.
OptiNose, Inc. (NASDAQ:OPTN) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the OptiNose's First Quarter 2023 Earnings Conference Call.
OptiNose, Inc. (NASDAQ:OPTN) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the OptiNose's Fourth Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.
OptiNose, Inc. (NASDAQ:OPTN) Q3 2022 Earnings Call Transcript
Jonathan Neely: Third quarter 2022 performance and our plans for the remainder of the year. I'm joined today by our CEO, Peter Miller; our President and Chief Operating Officer, Dr.
10 Best Penny Stocks to Buy in July
Penny stocks are priced under $5 and often represent high-risk public companies that do offer exponential growth potential.
Billionaire Hedge Funds
